Abstract:Abstract Background Mesenchymal stromal cells, which can be obtained in a large quantity from bone marrow easily, are non-hematopoietic multipotent stem cells that cannot differentiate into hematopoietic components in physiological condition. Induced pluripotent hematopoietic stem cells (iP-HSCs) may be an alternative graft source for autologous hematopoietic stem cell transplantation (HSCT) without malignant cell contamination and provide a disease-specific model for studying the underlying pathogenesis. This study aimed to generate putative induced pluripotent stem cells (iPSCs) from bone marrow-derived MSCs (BM-MSCs) using the plasmid pcDNA3.1, only containing OCT4. Methods BM-MSCs with stable ectopic OCT4 expression were established using a conventional plasmid vector, and then cultured in ES medium to form ESC-like clones. The obtained putative iPSCs were divided into two groups and treated with two different growth factor cocktails to induce differentiation into hematopoietic progenitor cells. Furthermore, putative iPSCs were injected subcutaneously into nude mice and the resulting cells were analyzed. Results The generated putative iPSCs were similar to human embryonic stem cells (ESCs) in terms of morphology, surface marker expression, telomerase activity and in vitro differentiation. CD34 + progenitor cells were obtained from the putative iPSCs following treatment with specific factors. The proportion of CD34 + progenitor cells were higher in differentiated cells (16.16 ± 1.27% and 25.40 ± 3.08% at days 14 and 21, respectively) compared to that of untransfected parental BM-MSCs (0.93 ± 0.46%) or undifferentiated cells (1.58 ± 1.29%) (P < 0.05) as determined using flow cytometry. After induction using the second growth factor cocktail and induction process,, the proportion of CD34 + cells reached 31.39 ± 3.60% and 73.68 ± 6.63% at days 14 and 21, respectively. These differentiated cells expressed the mesodermal hematopoietic transcription factor Brachyury. Conclusions This cell induction system developed in this study may provide a possible source of grafts-enriched CD34 + progenitor cells without malignant cell contamination for clinical use and to generate patient-specific cell models for studying of the mechanisms of hematopoiesis and related diseases.

Co-Expression of Runx1, Hoxa9, Hlf, and Hoxa7 Confers Multi-Lineage Potential on Hematopoietic Progenitors Derived From Pluripotent Stem Cells

Enhanced HSC-like Cell Generation from Mouse Pluripotent Stem Cells in a 3D Induction System Cocultured with Stromal Cells

Lineage-tracing hematopoietic stem cell origins in vivo to efficiently make human HLF+ HOXA+ hematopoietic progenitors from pluripotent stem cells

A Single-Cell Hematopoietic Landscape Resolves 8 Lineage Trajectories and Defects in Kit Mutant Mice.

Guiding T Lymphopoiesis from Pluripotent Stem Cells by Defined Transcription Factors

Reprogramming Committed Murine Blood Cells to Induced Hematopoietic Stem Cells with Defined Factors

Hypoxia Drives Hematopoiesis with the Enhancement of T Lineage Through Eliciting Arterial Specification of Hematopoietic Endothelial Progenitors from Hesc

Introduction of OCT4 into Human Bone-Marrow Derived Mesenchymal Stromal Cells Generates Putative Ips Cells with the Potential to Differentiate into CD34+ Hematopoietic Progenitor Cells Ex Vivo

The cdx-hox pathway in hematopoietic stem cell formation from embryonic stem cells.

Derivation of Hematopoietic Stem Cells from Embryonic Stem Cells

Characterization and generation of human definitive multipotent hematopoietic stem/progenitor cells

Haematopoietic stem and progenitor cells from human pluripotent stem cells

Inducible Overexpression of RUNX1b/c in Human Embryonic Stem Cells Blocks Early Hematopoiesis from Mesoderm.

OP9-Lhx2 Stromal Cells Facilitate Derivation of Hematopoietic Progenitors Both in Vitro and in Vivo

Respecifying Human Ipsc-Derived Blood Cells into Highly Engraftable Hematopoietic Stem and Progenitor Cells with a Single Factor.

Lin−PU.1dimGATA‐1− defines haematopoietic stem cells with long‐term multilineage reconstitution activity

Revisiting the lineage contribution of hematopoietic stem and progenitor cells

Pre-configuring chromatin architecture with histone modifications guides hematopoietic stem cell formation in mouse embryos

Hlf Expression Marks Early Emergence of Hematopoietic Stem Cell Precursors With Adult Repopulating Potential and Fate

Transcription factor Hoxb5 reveals the unidirectional hierarchy of hematopoietic stem cell pool

Efficient hemogenic endothelial cell specification by RUNX1 is dependent on baseline chromatin accessibility of RUNX1-regulated TGFβ target genes